Restless Leg Syndrome treatment has shifted dramatically: dopamine agonists are no longer first-line due to augmentation risks. Learn why alpha-2-delta ligands, iron therapy, and lifestyle changes now offer safer, more effective relief.
11 Jan
Orphan Drug Exclusivity: How Rare-Disease Medicines Get Market Protection
15 Dec
Baseline CK Testing for Statins: When It’s Really Needed
16 Dec
Bempedoic Acid Side Effects: Gout, Tendon Risks, and What You Need to Know
18 Nov
Compare Seroquel (Quetiapine) with Alternatives: What Works Best for Sleep, Mood, and Psychosis
1 Feb
Adolescents on ADHD Medications: Growth, Appetite, and Side Effect Monitoring